Ever Since US president Donald trump advocated Hydroxychloroquine, there has been much-heated debate over the past few months on the drug use fo treating COVID-19.
With the number of COVID-19 cases increasing every day, doctors are resorting to the use of pre-existing drugs in a desperate attempt to treat the virus. One such drug, also advocated by Trump is anti-malarial drugs- Hydroxychloroquine and chloroquine.
Recently a Washington based research team published their work proving the ineffectiveness of the drug. The conducted study was a high-quality experiment to test the said antimalarial drugs on people in close contact with someone affected by COVID-19. The test resulted in showing that hydroxychloroquine is no better than the placebo administered to the test group.
Though the administered dose of hydroxychloroquine did not cause any serious harm, about 40% of the participants portrayed side effects, mostly stomach ache.
“We were disappointed. We would have liked for this to work”, said the study leader, Dr. David Boulware, an infectious disease specialist at the University of Minnesota. “But our objective was to answer the question and to conduct a high-quality study because the evidence on the drug so far has been inconclusive”, he said.
The above studies prove that hydroxychloroquine has no effects over COVID-19, and it should be made aware of healthcare sectors all over not to use the drug on COVID-19 patients.
To know more about origin, virology of COVID-19, Click here
To know more about emerging themes in COVID-19, Click here
To know more about how WhiteCoats can help you in your professional advancement, visit www.whitecoats.com
Want to set up an online consultation for your practice, Click here